跳至主要内容
临床试验/NCT01147315
NCT01147315已完成不适用

10 Patients Bicentric Prospective Study of Hybrid Bone Substitution With Calcium-phosphate Ceramic Biomaterial and Autologous Bone Marrow for Mandibular Osteoradionecrosis (ORN) Treatment

Nantes University Hospital4 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2009年11月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
13
试验地点
4
主要终点
The cure of ORN

研究概览

简要总结

The main objective of the study is the cure of osteoradionecrosis (ORN) at 12 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (between 18 and 75 years) affiliated with an appropriate social security system, diagnosed as suffering from symptomatic ORN, radiologically confirmed, for which surgery is indicated
  • Presence maximum of 2 outbreaks of ORN
  • Oncological remission of the original tumor site for 1 year and for 3 years if the ORN is in the contact or close to the initial tumoral site
  • ECOG performance status 0, 1 or 2
  • ORN symptomatic accessible to the conservation of at least one cortical mandibular basilar
  • Signed informed consent

排除标准

  • Oncological treatment
  • Haematologic background
  • Current bone necrosis consecutive or concurrent to taking bisphosphonates
  • Extension of ORN does not allow the retention of a mandibular rod (bicortical form)
  • Presence of fracture complicating ORN
  • Bisphosphonates during the last year
  • Contraindications to the removal of iliac or sternum bone marrow
  • Contraindication for general anesthesia

结局指标

主要结局

The cure of ORN

时间窗: 12 months

次要结局

  • Quality of life
  • Number of hospital days
  • CT semiology description of the treated area
  • Bone regeneration
  • Safety of hybrid bone substitution
  • Evaluation of post operative pain at mandibular and bone marrow sampling site
  • Possibility of secondary dental prosthetic devices

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验